Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Isolagen Therapy (LAVIV) for Nasolabial Fold Wrinkles
NCT00655356Phase 3Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Nov 2006
- Primary completion
- Jul 2008
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 3 trial of azficel-t in nasolabial fold rhytides, sponsored by Castle Creek Biosciences. Started Nov 2006; status: completed.
02
Drugs
azficel-t
03
Conditions
nasolabial fold rhytides
Beyond the preview
Go deeper on NCT00655356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655356.